Literature DB >> 25458967

Pathophysiological mechanisms regulated by cytokines in gliomas.

Anthos Christofides1, Marinos Kosmopoulos1, Christina Piperi2.   

Abstract

Glioma, a neuroglia originated malignancy, consists of one of the most aggressive primary tumors of the central nervous system with poor prognosis and lack of efficient treatment strategy. Cytokines have been implicated in several stages of glioma progression, participating in tumor onset, growth enhancement, angiogenesis and aggressiveness. Interestingly, cytokines have also the ability to inhibit glioma growth upon specific regulation or interplay with other molecules. This review addresses the dual role of major cytokines implicated in glioma pathology, pointing toward promising therapeutic approaches.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokines; Glioma; IL-18; TGF-β; TNF

Mesh:

Substances:

Year:  2014        PMID: 25458967     DOI: 10.1016/j.cyto.2014.09.008

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  17 in total

1.  Prognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients.

Authors:  Adomas Bunevicius; Andrius Radziunas; Sarunas Tamasauskas; Arimantas Tamasauskas; Edwards R Laws; Giorgio Iervasi; Robertas Bunevicius; Vytenis Deltuva
Journal:  J Neurooncol       Date:  2018-02-19       Impact factor: 4.130

Review 2.  The neuropathological basis to the functional role of microglia/macrophages in gliomas.

Authors:  Davide Schiffer; Marta Mellai; Enrica Bovio; Laura Annovazzi
Journal:  Neurol Sci       Date:  2017-06-07       Impact factor: 3.307

3.  The role of interleukin-18 in glioblastoma pathology implies therapeutic potential of two old drugs-disulfiram and ritonavir.

Authors:  Richard E Kast
Journal:  Chin J Cancer       Date:  2015-04-09

4.  WITHAFERIN A INDUCES APOPTOSIS IN RAT C6 GLIOMA CELLS THROUGH REGULATING NF-KB NUCLEAR TRANSLOCATION AND ACTIVATION OF CASPASE CASCADE.

Authors:  Wei-Chen Hou; Xiao-Hui Miao; Lian-Jun Ma; Xiao-Xue Bai; Qun Liu; Lei Song
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-01-13

5.  Circadian Alterations in a Murine Model of Hypothalamic Glioma.

Authors:  José M Duhart; Lucila Brocardo; Carlos S Caldart; Luciano Marpegan; Diego A Golombek
Journal:  Front Physiol       Date:  2017-10-30       Impact factor: 4.566

6.  Entry and exit of chemotherapeutically-promoted cellular dormancy in glioblastoma cells is differentially affected by the chemokines CXCL12, CXCL16, and CX3CL1.

Authors:  Vivian Adamski; Kirsten Hattermann; Carolin Kubelt; Gesa Cohrs; Ralph Lucius; Michael Synowitz; Susanne Sebens; Janka Held-Feindt
Journal:  Oncogene       Date:  2020-04-28       Impact factor: 9.867

Review 7.  The Role of Selected Chemokines and Their Receptors in the Development of Gliomas.

Authors:  Magdalena Groblewska; Ala Litman-Zawadzka; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2020-05-24       Impact factor: 5.923

8.  A New Role for Helicobacter pylori Urease: Contributions to Angiogenesis.

Authors:  Deiber Olivera-Severo; Augusto F Uberti; Miguel S Marques; Marta T Pinto; Maria Gomez-Lazaro; Céu Figueiredo; Marina Leite; Célia R Carlini
Journal:  Front Microbiol       Date:  2017-09-27       Impact factor: 5.640

9.  NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway.

Authors:  Xiao-Feng Yin; Qiong Zhang; Zhuo-Yu Chen; Hai-Fang Wang; Xin Li; Hong-Xia Wang; Hai-Xia Li; Chun-Min Kang; Shuai Chu; Kai-Fei Li; Yao Li; Yu-Rong Qiu
Journal:  Int J Oncol       Date:  2018-07-12       Impact factor: 5.650

10.  Clinical and Biological Correlates of Preoperative Cognitive Functioning of Glioma and Meningioma Patients.

Authors:  Aiste Pranckeviciene; Vytenis P Deltuva; Arimantas Tamasauskas; Jurate Zegliene; Adomas Bunevicius
Journal:  Biomed Res Int       Date:  2020-05-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.